marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-08-2024
Arrowhead Pharmaceuticals Financial Ratios 2011-2024 | ARWR
Annual Financial Ratios Arrowhead Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-15.1 | -17.2 | -32.4 | -94.1 | 55.3 | -19.1 | -7.8 | -4.4 | -3.2 | -5.4 | -5.4 | -1.1 | -11.9 |
P/S |
12.9 | 12.4 | 33.0 | 90.4 | 22.3 | 64.6 | 8.6 | 2261.5 | 773.3 | 1804.9 | 574.7 | 164.4 | 126.1 |
EPS |
-1.9 | -1.7 | -1.4 | -0.8 | 0.7 | -0.7 | -0.5 | -1.3 | -1.6 | -1.2 | -1.3 | -1.9 | -0.4 |
EV (Enterprise Value) |
2.98 B | 2.91 B | 4.38 B | 7.81 B | 3.64 B | 1.03 B | 268 M | 306 M | 237 M | 200 M | 159 M | 28.5 M | 33.2 M |
EBITDA per Share |
-1.82 | -1.61 | -1.37 | -0.88 | 0.699 | -0.613 | -0.437 | -1.25 | -1.63 | -1.06 | -0.897 | -1.74 | -1.34 |
EV/EBITDA |
-30.8 | -64.5 | 53.9 | -19.8 | -7.7 | -3.6 | -2.3 | -3.7 | -6.9 | -1.1 | -3.2 | ||
PEG |
0.21 | 0.26 | 0.4 | 0.96 | 0.26 | 0.5 | -0.12 | -0.27 | 0.11 | -1.4 | -0.17 | 0.0 | -0.23 |
P/B |
4.0 | 4.4 | 6.4 | 15.2 | 15.4 | 10.9 | 3.3 | 3.8 | 2.7 | 1.9 | 6.5 | 2.7 | 3.0 |
P/CF |
-20.1 | -22.2 | 26.6 | -83.1 | 23.3 | -21.4 | -8.5 | -5.2 | -4.4 | -8.5 | -8.6 | -1.5 | -6.9 |
ROE % |
-75.65 | -44.18 | -34.45 | -18.31 | 27.85 | -57.17 | -42.51 | -86.00 | -83.87 | -35.32 | -121.02 | -239.82 | -24.90 |
ROA % |
-26.81 | -25.44 | -19.83 | -16.18 | 19.43 | -48.79 | -33.05 | -63.76 | -69.51 | -32.07 | -83.43 | -127.82 | -19.69 |
ROCE % |
-31.82 | -33.47 | -26.44 | -19.33 | 24.21 | -56.36 | -43.36 | -77.72 | -82.48 | -29.89 | -81.39 | -188.30 | -73.88 |
Current Ratio |
- | - | - | - | 2.7 | 6.4 | 3.6 | 3.5 | 6.5 | 13.1 | 3.3 | 1.2 | 3.8 |
DSO |
- | 8.8 | 14.6 | 3.1 | 1.4 | 7.4 | 0.8 | 172.9 | - | - | 105.2 | 6126.8 | 1982.4 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 8.8 | 14.7 | 3.1 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 8.8 | 14.7 | 3.1 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Arrowhead Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.38 | -1.02 | -1.24 | - | -0.96 | 0.46 | -0.39 | - | -0.68 | 0.42 | -0.6 | - | -0.29 | -0.26 | -0.2 | -0.48 | -0.13 | -0.2 | -0.03 | 0.12 | 0.21 | -0.03 | 0.13 | -0.12 | -0.18 | 0.13 | -0.18 | -0.14 | -0.07 | -0.18 | -0.17 | -0.34 | -0.32 | -0.17 | -0.32 | -0.42 | -0.27 | -0.32 | -0.41 | -0.42 | -0.22 | -0.41 | -0.28 | -0.43 | -0.23 | -0.41 | -0.33 | -1.48 | -0.71 | -0.5 | -0.25 | -0.05 | -0.25 | 0.4 |
EBITDA per Share |
-1.38 | -0.99 | -1.24 | - | -0.93 | 0.47 | -0.38 | - | -0.67 | 0.41 | -0.59 | - | -0.29 | -0.26 | -0.22 | -0.47 | -0.15 | -0.22 | -0.04 | 0.13 | 0.2 | -0.04 | 0.13 | -0.09 | -0.16 | 0.13 | -0.17 | -0.09 | -0.06 | -0.17 | -0.19 | -0.32 | -0.31 | -0.19 | -0.31 | -0.42 | -0.26 | -0.31 | -0.45 | -0.48 | -0.24 | -0.45 | -0.18 | -0.35 | -0.23 | 0.07 | -0.31 | -1.35 | -0.57 | -0.41 | -0.35 | -0.18 | -0.24 | -0.5 |
ROE % |
-187.35 | -162.63 | -126.26 | -26.91 | -42.10 | -30.35 | -31.00 | -22.26 | -29.11 | -20.76 | -37.77 | -18.61 | -26.43 | -22.34 | -19.34 | -15.31 | 15.52 | 26.59 | 29.69 | 37.22 | -31.39 | -55.99 | -42.34 | -67.99 | -35.56 | -26.05 | -46.04 | -39.74 | -49.81 | -63.35 | -77.71 | -86.08 | -85.29 | -79.43 | -75.14 | -69.84 | -60.85 | -53.37 | -49.44 | -46.85 | -83.18 | -98.30 | -123.40 | -161.96 | -270.09 | -327.80 | -335.23 | -299.19 | -1030.23 | -964.64 | -937.99 | -888.96 | -14.23 | -19.43 |
ROA % |
-66.59 | -60.20 | -41.62 | -12.11 | -12.11 | 7.13 | 7.98 | 2.77 | -7.61 | -11.68 | -21.77 | -12.00 | -18.91 | -17.45 | -17.64 | -13.94 | 9.06 | 17.47 | 20.68 | 24.66 | -30.57 | -50.36 | -38.81 | -57.30 | -28.48 | -19.80 | -36.39 | -29.81 | -36.83 | -46.68 | -57.11 | -66.02 | -67.40 | -64.29 | -62.62 | -59.25 | -52.81 | -47.12 | -44.90 | -42.45 | -66.85 | -76.78 | -92.90 | -111.73 | -170.72 | -202.79 | -202.23 | -182.72 | -802.70 | -765.81 | -753.53 | -715.66 | -11.45 | -15.64 |
ROCE % |
-76.00 | -67.53 | -47.18 | -13.64 | -29.02 | -30.24 | -28.87 | -20.64 | -26.55 | -17.08 | -29.79 | -16.33 | -26.74 | -23.94 | -23.26 | -19.13 | -4.92 | 5.52 | 8.29 | 14.52 | -0.48 | -23.77 | -10.88 | -34.58 | -35.32 | -26.03 | -53.08 | -48.50 | -57.70 | -69.81 | -68.18 | -73.78 | -74.22 | -69.13 | -71.22 | -68.41 | -59.86 | -53.59 | -51.69 | -43.28 | -56.59 | -70.22 | -78.66 | -116.17 | -216.49 | -250.30 | -265.99 | -242.21 | -166.66 | -124.90 | -115.96 | -51.11 | -13.08 | -29.84 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | 206.2 | 34.2 | 33.4 | - | 1.9 | 0.4 | 17.3 | - | 10.9 | 26.8 | 21.1 | 10.1 | 2.8 | 4.7 | 3.1 | 1.4 | 1.4 | 5.9 | 4.6 | 2.6 | 41.1 | 33.5 | 2.8 | 0.7 | 0.7 | 1.7 | 1.4 | 219.0 | 172.9 | 0.8 | - | - | - | 132.4 | 33.9 | - | - | 20.0 | 156.4 | 156.4 | 156.4 | 198.4 | 35.8 | 8.3 | 17.9 | 2.7 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 112.0 | - | 108.7 | 99.0 | 170.0 | 90.9 | 271.4 | 186.9 | 120.1 | 44.7 | 128.6 | 128.3 | 124.2 | 30.8 | 95.9 | 45.9 | 39.2 | 21.9 | 66.3 | 44.0 | 47.2 | 16.1 | 48.4 | 44.6 | 44.6 | 48.4 | 148.6 | - |
Operating Cycle |
- | - | - | - | 206.2 | 34.2 | 33.4 | - | 1.9 | 0.4 | 17.3 | - | 10.9 | 26.8 | 21.1 | 10.1 | 2.8 | 4.7 | 3.1 | 1.4 | 1.4 | 5.9 | 4.6 | 2.6 | 41.1 | 33.5 | 2.8 | 0.7 | 0.7 | 1.7 | 1.4 | 219.0 | 172.9 | 0.8 | - | - | - | 132.4 | 33.9 | - | - | 20.0 | 156.4 | 156.4 | 156.4 | 198.4 | 35.8 | 8.3 | 17.9 | 2.7 | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | 206.2 | 34.2 | 33.4 | - | 1.9 | 0.4 | 17.3 | - | 10.9 | 26.8 | 21.1 | 10.1 | 2.8 | 4.7 | 3.1 | 1.4 | 1.4 | 5.9 | 4.6 | 2.6 | 41.1 | 33.5 | -109.2 | 0.7 | -108.1 | -97.3 | -168.6 | 128.1 | -98.5 | -186.2 | -120.1 | -44.7 | -128.6 | 4.1 | -90.2 | -30.8 | -95.9 | -25.9 | 117.2 | 134.6 | 90.2 | 154.4 | -11.5 | -7.8 | -30.6 | -41.9 | -44.6 | -48.4 | -148.6 | - |
All numbers in USD currency